Three major investors are pushing medical device maker Smith & Nephew to consider a break-up of the business, the Financial Times reported on Thursday, citing shareholders. The UK-headquartered ...
Additional returns to be executed in share buyback and cancellation worth KRW 150 billion within the year, with total return to shareholders exceeding 100 percent Under the plan, KT&G aims to ...